Lamb, R., Harrison, H., Hulit, J., Smith, D. L., Lisanti, M. P., & Sotgia, F. (2014). Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1/2 inhibition. Oncotarget, 5(22), 11029. https://doi.org/10.18632/oncotarget.2789
Chicago Style (17th ed.) CitationLamb, Rebecca, Hannah Harrison, James Hulit, Duncan L. Smith, Michael P. Lisanti, and Federica Sotgia. "Mitochondria as New Therapeutic Targets for Eradicating Cancer Stem Cells: Quantitative Proteomics and Functional Validation via MCT1/2 Inhibition." Oncotarget 5, no. 22 (2014): 11029. https://doi.org/10.18632/oncotarget.2789.
MLA (9th ed.) CitationLamb, Rebecca, et al. "Mitochondria as New Therapeutic Targets for Eradicating Cancer Stem Cells: Quantitative Proteomics and Functional Validation via MCT1/2 Inhibition." Oncotarget, vol. 5, no. 22, 2014, p. 11029, https://doi.org/10.18632/oncotarget.2789.